The FDA has approved Boston Scientific's VICI VENOUS STENT System for the treatment of iliofemoral venous obstructive disease. The stent system received CE Mark in 2013 and came over to Boston Scientific in their acquisition of VENITI....
Healthcare has benefited tremendously from information technology. Given the need for precision and the deadly consequences of seemingly tiny errors, IT has helped lower costs, increase efficiency and reduce mistakes in the medical industry. Nevertheless, for all the good that technology has done for medical device manufacturing, pharmaceutical production and hospital record management, it has introduced new challenges....
3M has agreed to buy San Antonio, TX medical device company, Acelity, in a deal valued close to $6.7 billion....
The FDA has granted Levita Magnetics an expanded indication to market their Levita Magnetic Surgical System for use in prostatectomy procedures. The system was initially indicated for use in laparoscopic cholecystectomy (gallbladder removal) and bariatric surgical procedures....
Medtronic announced the U.S. launch of the Solitaire X Revascularization Device, which mechanically removes blood clots from blocked vessels in the brain to restore blood flow in patients suffering an acute ischemic stroke with large vessel occlusion....
Earlier this week, reports of layoffs at Medtronic's Heartware location started showing up on our Medtronic company forum. According to the Heartware website, their corporate office is located in Framingham, MA with operations...
Earlier today, there were reports on our Medtronic forums of layoffs at the Medtronic's Heartware location. According to the Heartware website, their corporate office is located in Framingham, MA with operations, manufacturing and distribution centers in Miami Lakes, FL and Arden Hills, MN. We have reached out to Medtronic for comment....
Boston Scientific received FDA approval for their LOTUS Edge Aortic Valve System, which is a transcatheter aortic valve replacement (TAVR) used for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open heart surgery....
The FDA has approved marketing authorization of the first medical device to treat attention deficit hyperactivity disorder (ADHD) in children. The device was developed by NeuroSigma and is called the Monarch eTNS System. ...
​Johnson & Johnson released Q1 2019 earnings yesterday coming in with $20.02 billion in revenue compared to the street's projection of $19.61 billion. ...